AEON Biopharma, Inc.
$1.07
▼
-9.16%
2026-04-21 05:07:00
www.aeonbiopharma.com
ASE: AEON
Explore AEON Biopharma, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$25.81 M
Current Price
$1.07
52W High / Low
$1.45 / $0.38
Stock P/E
—
Book Value
$-4.54
Dividend Yield
—
ROCE
252.78%
ROE
-46.26%
Face Value
—
EPS
$-3.95
Exp Qtr EPS
—
Sector
Healthcare
Industry
Biotechnology
Employees
8
Beta
0.73
Debt / Equity
-0.45
Current Ratio
0.49
Quick Ratio
0.49
Forward P/E
-1.22
Price / Sales
—
Enterprise Value
$53.99 M
EV / EBITDA
-3.33
EV / Revenue
—
Rating
Strong Buy
Target Price
$6.7
EPS Forecast (FY)
—
Pros
- Efficient use of capital employed.
- Balance sheet leverage appears manageable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Current ratio suggests tighter short-term liquidity.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Heron Therapeutics, Inc. | $1.05 | — | $187.09 M | — | -1.59% | 209.08% | $2.61 / $0.74 | $0.07 |
| 2. | MiMedx Group, Inc. | $3.25 | 10.44 | $507.35 M | — | 22.95% | 21.61% | $7.99 / $3.31 | $1.73 |
| 3. | Lisata Therapeutics, Inc. | $2.83 | — | $25.56 M | — | -124.1% | -75.53% | $5.07 / $1.81 | $1.68 |
| 4. | Beam Therapeutics Inc. | $31.19 | — | $3.2 B | — | -27.72% | -8.11% | $36.44 / $15.35 | $12.48 |
| 5. | Dianthus Therapeutics, Inc. | $91.92 | — | $5 B | — | -35.57% | -38.38% | $96.5 / $16.64 | $11.41 |
| 6. | Outlook Therapeutics, Inc. | $0.37 | — | $38.71 M | — | 246.27% | 118.61% | $3.39 / $0.16 | $-0.6 |
| 7. | BeyondSpring Inc. | $1.78 | — | $73 M | — | -72.39% | 3.09% | $3.44 / $1.21 | $-0.8 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 0 M | 0 M | 0 M | 0 M | 0 M | — |
| Operating Profit | -5.5 M | -2.53 M | -4.32 M | -3.95 M | -5.67 M | — |
| Net Profit | -37.14 M | -4.54 M | -6.64 M | 9.1 M | 2.08 M | — |
| EPS in Rs | -1.47 | -0.18 | -0.26 | 0.36 | 0.08 | -11.24 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 0 M | 0 M | — | 0 M |
| Operating Profit | -16.3 M | -27.82 M | — | -48.43 M |
| Net Profit | -39.22 M | 42.01 M | — | -52.56 M |
| EPS in Rs | -1.55 | 1.66 | — | -2.08 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 5.56 M | 3.14 M | 6.84 M | 10.78 M |
| Total Liabilities | 60.59 M | 31.71 M | 159.89 M | 281.19 M |
| Equity | -55.03 M | -28.57 M | -153.04 M | -287.5 M |
| Current Assets | 3.4 M | 1.59 M | 6.22 M | 9.84 M |
| Current Liabilities | 6.9 M | 14.15 M | 13.05 M | 82.57 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2022 | 2021 | |
|---|---|---|---|---|
| Operating CF | -17.31 M | -20.29 M | -35.58 M | -28.43 M |
| Investing CF | -0 M | 0 M | -0.31 M | -0.17 M |
| Financing CF | 20.3 M | 15.15 M | 40.51 M | 13.56 M |
| Free CF | -17.31 M | -20.29 M | -35.89 M | -28.6 M |
| Capex | -0 M | — | -0.31 M | -0.17 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | — | — | — | — |
| Earnings Growth % | — | — | 5.54% | — |
| Profit Margin % | — | — | — | — |
| Operating Margin % | — | — | — | — |
| Gross Margin % | — | — | — | — |
| EBITDA Margin % | — | — | — | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
| Date | Split |
|---|---|
| 2025-02-26 | 1:0.0138889 |